These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7352028)
1. Evidence for a role of plasma kallikrein in the activation of prorenin. Rumpf KW; Becker K; Kreusch U; Schmidt S; Vetter R; Scheler F Nature; 1980 Jan; 283(5746):482-3. PubMed ID: 7352028 [No Abstract] [Full Text] [Related]
2. Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein. Yokosawa N; Takahashi N; Inagami T; Page DL Biochim Biophys Acta; 1979 Aug; 569(2):211-9. PubMed ID: 476126 [TBL] [Abstract][Full Text] [Related]
3. Partial purification of prorenin and activation by kallikreins: a possible new link between renin and kallikrein systems. Inagami T; Yokosawa N; Takahashi N; Takii Y Adv Exp Med Biol; 1979; 120B():415-28. PubMed ID: 517242 [TBL] [Abstract][Full Text] [Related]
4. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5914-8. PubMed ID: 42905 [TBL] [Abstract][Full Text] [Related]
5. Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin. Derkx FH; Schalekamp MP; Bouma B; Kluft C; Schalekamp MA J Clin Endocrinol Metab; 1982 Feb; 54(2):343-8. PubMed ID: 6459340 [TBL] [Abstract][Full Text] [Related]
6. Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Sealey JE; Atlas SA; Laragh JH; Oza NB; Ryan JW Nature; 1978 Sep; 275(5676):144-5. PubMed ID: 692685 [No Abstract] [Full Text] [Related]
7. Prorenin processing and restricted endoproteolysis by mouse tissue kallikrein family enzymes (mK1, mK9, mK13, and mK22). Kikkawa Y; Yamanaka N; Tada J; Kanamori N; Tsumura K; Hosoi K Biochim Biophys Acta; 1998 Jan; 1382(1):55-64. PubMed ID: 9507064 [TBL] [Abstract][Full Text] [Related]
8. Characterization of prorenin activation using a synthetic peptide substrate. Dubin D; Pratt RE; Hui KY; Dzau VJ J Hypertens; 1991 Jun; 9(6):483-6. PubMed ID: 1653285 [TBL] [Abstract][Full Text] [Related]
9. Salivary gland tissue kallikrein family and processing of growth factor precursors and proenzymes. Hosoi K; Kurabuchi S; Kikkawa Y; Tada J; Akamatsu T; Yamanaka N; Matsumoto T; Kanamori N; Tsumura K Eur J Morphol; 1998 Aug; 36 Suppl():82-5. PubMed ID: 9825898 [TBL] [Abstract][Full Text] [Related]
10. Plasma kallikrein and prorenin in patients with hereditary angioedema. Purdon AD; Schapira M; De Agostini A; Colman RW J Lab Clin Med; 1985 Jun; 105(6):694-9. PubMed ID: 3889200 [TBL] [Abstract][Full Text] [Related]
11. Plasma kallikrein and plasmin as activators of prorenin: links between the renin-angiotensin system and other proteolytic systems in plasma. Schalekamp MA; Derkx FH Clin Sci (Lond); 1981 Jul; 61(1):15-21. PubMed ID: 6454526 [No Abstract] [Full Text] [Related]
12. Activation of inactive plasma renin by tissue kallikreins. Derkx FH; Tan-Tjiong HL; Man in't Veld AJ; Schalekamp MP; Schalekamp MA J Clin Endocrinol Metab; 1979 Nov; 49(5):765-9. PubMed ID: 489716 [TBL] [Abstract][Full Text] [Related]
13. Relationship between urinary kallikrein excretion and the extent of circulating inactive renin activation by the kidney. Jindra A; Ort J; Peleska J; Umnerová V; Jáchymová M Agents Actions Suppl; 1987; 22():257-63. PubMed ID: 3324712 [No Abstract] [Full Text] [Related]
14. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054 [TBL] [Abstract][Full Text] [Related]
15. Acid-activatable inactive renin in cat plasma and kidney. Glorioso N; Troffa C; Atlas SA; Sealey JE J Hypertens Suppl; 1986 Dec; 4(5):S6-9. PubMed ID: 3553486 [TBL] [Abstract][Full Text] [Related]
16. Activation of plasma and amniotic prorenin by metalloprotease and trypsin. Takada Y; Brown SW; Erdös EG J Clin Endocrinol Metab; 1986 Mar; 62(3):569-76. PubMed ID: 3511083 [TBL] [Abstract][Full Text] [Related]
17. Extraction of plasma prorenin by human heart. Skinner SL; Thatcher RL; Whitworth JA; Horowitz JD Lancet; 1986 May; 1(8488):995-7. PubMed ID: 2871332 [TBL] [Abstract][Full Text] [Related]
18. Captopril-induced changes on active and inactive renin in a patient with factor XII congenital deficiency. Patrassi GM; Mantero F; Fallo F; Girolami A; Derkx FH Res Exp Med (Berl); 1985; 185(3):217-20. PubMed ID: 3895336 [TBL] [Abstract][Full Text] [Related]
19. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome. Itskovitz-Eldor J; Kol S; Lewit N; Sealey JE J Clin Endocrinol Metab; 1997 Feb; 82(2):461-4. PubMed ID: 9024237 [TBL] [Abstract][Full Text] [Related]
20. Contact activation of human plasma prorenin in vitro. Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]